Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Valeo Pharma Inc
VPHIF
Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,...
Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:VPHIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(6)
•••
Marketwatchman
X
View Profile
View Bullboard History
Post by
Marketwatchman
on Sep 12, 2021 9:55am
VPH
Valeo pharma is very quiet these days !
(6)
•••
Marketwatchman
X
View Profile
View Bullboard History
Comment by
Marketwatchman
on Aug 17, 2021 1:07pm
RE:VPH
Fidelity must have confidence in Valeo, he continues to buy...
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(129)
•••
Uteck1000
X
View Profile
View Bullboard History
Comment by
Uteck1000
on Aug 07, 2021 6:56pm
RE:RE:RE:VPH
I sent an email to the CEO on Friday with reference to my last post. Haven’t heard back but probably should have been through IR as you suggested.
(51)
•••
kooter33
X
View Profile
View Bullboard History
Comment by
kooter33
on Aug 07, 2021 5:07pm
RE:RE:VPH
great thought! Throw it at the company via IR. See what he/they say. VPH is not standing still. New products will be introduced to the CDN market so why not this inhaler. Tetra
...more
(129)
•••
Uteck1000
X
View Profile
View Bullboard History
Comment by
Uteck1000
on Aug 05, 2021 10:13pm
RE:VPH
Dr.Brilliant was speaking on CNBC this evening and was indicating that the covid 19 administration may very well be headed towards a mist inhaling device and will be used all around the world. VPH is
...more
(6)
•••
Marketwatchman
X
View Profile
View Bullboard History
Post by
Marketwatchman
on Aug 04, 2021 11:59am
VPH
Fidelity... keep buying VALEO
(559)
•••
chrispi
X
View Profile
View Bullboard History
Comment by
chrispi
on Jul 23, 2021 8:46am
RE:RE:see you in Sept
sorry, wrong board.
(559)
•••
chrispi
X
View Profile
View Bullboard History
Comment by
chrispi
on Jul 23, 2021 8:46am
RE:see you in Sept
really ... nothing ... before Sept? I'll take the other side of that bet. How about two more study results being released before then.
(6)
•••
Marketwatchman
X
View Profile
View Bullboard History
Comment by
Marketwatchman
on Jul 21, 2021 9:15am
RE:RE:RE:VPH: very oversold under $1.00!
Anonymous can surprise a lot of investors... They don't seem to want Valeo increase its value !
(10)
•••
Royal10
X
View Profile
View Bullboard History
Comment by
Royal10
on Jul 20, 2021 2:32pm
RE:RE:VPH: very oversold under $1.00!
Looks like ANONYMOUS has finished selling!
(10)
•••
Royal10
X
View Profile
View Bullboard History
Comment by
Royal10
on Jul 19, 2021 10:50am
RE:VPH: very oversold under $1.00!
VPH is holding well today. Good news: an insider bought 150,000 shares at these depressed prices according to INK Researck (July 19th). Fidelity continues to accumulate too.
(6)
•••
Marketwatchman
X
View Profile
View Bullboard History
Post by
Marketwatchman
on Jul 15, 2021 5:35pm
VPH
OUFFFFFF......?????? 0.64 wow, where are they going ????
(10)
•••
Royal10
X
View Profile
View Bullboard History
Post by
Royal10
on Jul 15, 2021 10:07am
VPH: very oversold under $1.00!
An investor sold more than 5 million shares in the last two weeks, under the ANONYMOUS founction. So, at 70 cents today, VPH is very oversold!
(51)
•••
kooter33
X
View Profile
View Bullboard History
Post by
kooter33
on Jul 09, 2021 10:53am
Rich TV Interview with Steve Saviuk
https://www.youtube.com/watch?v=SDAyH53ZEcU
(51)
•••
kooter33
X
View Profile
View Bullboard History
Post by
kooter33
on Jul 07, 2021 1:21pm
see you in Sept
obviously nothing going to happen before Sept 2021. Q3 report due out before Oct 4th. MHI Montreal Heart Institute study on Hesperidin to be published sometime this summer? Yawn
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips